Antithymocyte immunoglobulin (rabbit) Recruiting Phase 4 Trials for Lymphoma, Lymphoblastic Treatment

IndicationsStatusPurposePhase
RecruitingTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT02938741ATG Based Conditioning Regimen in HLA Related HSCT for Aggressive T-cell Tumors